Semaglutide and GLP1 agonists are becoming more popular with regards to treatment of obesity. They're a gut hormone that's produced by primarily the small intestine. It increases insulin secretion to help cover the glucose that you ate in your meal. And it also signals to the brain to increase satiety or fullness. So they just are much more effective than anything that came before them, more effective and more safe.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode